Patent · US Active

Redox-based reagents for methionine bioconjugation

US11353463B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 2, 2019
Grant dateJun 7, 2022
Priority date
Expiry dateJul 3, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2458/15
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Chemoselective conjugation is achieved through redox reactivity by reacting an N-transfer oxidant with a thioether substrate in a redox reaction in an aqueous environment to form a conjugation product. In embodiments, Redox-Activated Chemical Tagging (ReACT) strategies for methionine-based protein functionalization. Oxaziridine (Ox) compounds serve as oxidant-mediated reagents for direct functionalization by converting methionine to the corresponding sulfimide conjugation product.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.